COMMONWEALTH OF AUSTRALIA
Instrument number PB 41 of 2011
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2011 - Specification Under Subsection 84AAA(2)
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 19 May 2011
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — Pharmaceutical Benefits - Early Supply
1 Name of Instrument
(1) This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment June 2011 - specification under subsection 84AAA(2).
(2) This Instrument may also be cited as No. PB 41 of 2011.
2 Commencement
This Instrument commences on 1 June 2011.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.
Schedule 1 Amendments
[1] Schedule 1, after item dealing with Risedronic acid, Tablet 35 mg
insert in the columns in the order indicated:
| | Tablet (enteric coated) containing risedronate sodium 35mg | Oral | 4 | 5 | |
[2] Schedule 1, after item dealing with Risedronic acid
omit:
| Risedronate sodium and calcium carbonate | Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium) | Oral | 1 | 5 | |
| Risedronate sodium and calcium carbonate with colecalciferol | Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g (equivalent to 1 g calcium) with colecalciferol 22 micrograms | Oral | 1 | 5 | |
[3] Schedule 1, after item dealing with Risedronic acid and calcium, Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)
insert in the columns in the order indicated:
| | Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) | Oral | 1 | 5 | |
[4] Schedule 1, after item dealing with Risedronic acid and calcium with colecalciferol, Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms
insert in the columns in the order indicated:
| | Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms | Oral | 1 | 5 | |
[5] Schedule 1, after item dealing with Telmisartan
insert in the columns in the order indicated:
| Telmisartan with amlodipine | Tablet 40 mg-5 mg (as besylate) | Oral | 28 | 5 | |
| Tablet 40 mg-10 mg (as besylate) | Oral | 28 | 5 | |
| Tablet 80 mg-5 mg (as besylate) | Oral | 28 | 5 | |
| Tablet 80 mg-10 mg (as besylate) | Oral | 28 | 5 | |